3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
6
Sarcoma
3
Endocrine
2
Thoracic
1
NET
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
Conditions
Neuroendocrine Tumors
73
Pheochromocytoma
8
Gastro-enteropancreatic neuroendocrine tumor
8
Paraganglioma
7
Carcinoma, Neuroendocrine
7
Carcinoid Tumor
7
Adenoma, Islet Cell
7
Thyroid Neoplasms
5
Sarcoma
5
Pancreatic Neoplasms
5
Neoplasms
5
Melanoma
5
Breast Neoplasms
5
Prostatic Neoplasms
4
Neuroblastoma
4
Neoplasm Metastasis
4
Mesothelioma
4
Carcinoma, Merkel Cell
4
Carcinoma
4
Stomach Neoplasms
3
Ovarian Neoplasms
3
Neuroectodermal Tumors, Primitive
3
Meningioma
3
Liver Neoplasms
3
Colorectal Neoplasms
3
Colonic Neoplasms
3
Cholangiocarcinoma
3
Central Nervous System Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Medullary
3
Interventions
olaparib
1
lutetium Lu 177 dotatate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Esthesioneuroblastoma, Olfactory
×
NET
×
90 days
×
Clear all
NCT06607692
2026-06-04
LUPARPED
Fundación de investigación HM
Phase 1/2
Recruiting
25 enrolled